These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12704661)

  • 41. Esophageal squamous carcinoma in five patients with Barrett's esophagus.
    Paraf F; Fléjou JF; Potet F; Molas G; Fékété F
    Am J Gastroenterol; 1992 Jun; 87(6):746-50. PubMed ID: 1590313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
    Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
    Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus.
    Vallböhmer D; DeMeester SR; Oh DS; Banki F; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; Chandrasoma PT; Peters JH; DeMeester TR
    Am J Gastroenterol; 2006 Jul; 101(7):1458-66. PubMed ID: 16863546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus.
    Olyaee M; Sontag S; Salman W; Schnell T; Mobarhan S; Eiznhamer D; Keshavarzian A
    Gut; 1995 Aug; 37(2):168-73. PubMed ID: 7557561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma and esophageal mucosal levels of vitamin C: role in the pathogenesis and neoplastic progression of Barrett's esophagus.
    Fountoulakis A; Martin IG; White KL; Dixon MF; Cade JE; Sue-Ling HM; Wild CP
    Dig Dis Sci; 2004 Jun; 49(6):914-9. PubMed ID: 15309877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adenocarcinoma of Cervical Esophagus Arising in the Barrett's Mucosa.
    Sundriyal D; Shirsi N; Kotwal S; Kumar S; Mithran Parthasarthy K; Gupta M
    Indian J Surg Oncol; 2015 Jun; 6(2):127-9. PubMed ID: 26405420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Developmental expression of plasma glutathione peroxidase during mouse organogenesis.
    Jung KY; Baek IJ; Yon JM; Lee SR; Kim MR; Lee BJ; Yun YW; Nam SY
    J Mol Histol; 2011 Dec; 42(6):545-56. PubMed ID: 21948268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Squamous Papilloma After Endoscopic Ablation of Barrett's Esophagus: A Case Report and Review of Literature.
    Abdallah A; Atiq M; Murray A; Patel J
    S D Med; 2019 May; 72(5):200-202. PubMed ID: 31454472
    [No Abstract]   [Full Text] [Related]  

  • 49. Cellular and subcellular localization of gastrointestinal glutathione peroxidase in normal and malignant human intestinal tissue.
    Florian S; Wingler K; Schmehl K; Jacobasch G; Kreuzer OJ; Meyerhof W; Brigelius-Flohé R
    Free Radic Res; 2001 Dec; 35(6):655-63. PubMed ID: 11811519
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological and Catalytic Properties of Selenoproteins.
    Chaudière J
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The beginning of GPX2 and 30 years later.
    Esworthy RS; Doroshow JH; Chu FF
    Free Radic Biol Med; 2022 Aug; 188():419-433. PubMed ID: 35803440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma.
    Du H; Chen B; Jiao NL; Liu YH; Sun SY; Zhang YW
    Oxid Med Cell Longev; 2020; 2020():7370157. PubMed ID: 32215178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of epithelium-specific GPx2 results in aberrant cell fate decisions during intestinal differentiation.
    Lennicke C; Rahn J; Wickenhauser C; Lichtenfels R; Müller AS; Wessjohann LA; Kipp AP; Seliger B
    Oncotarget; 2018 Jan; 9(1):539-552. PubMed ID: 29416634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogen-Dependent Nrf2 Expression Protects Against Reflux-Induced Esophagitis.
    Torihata Y; Asanuma K; Iijima K; Mikami T; Hamada S; Asano N; Koike T; Imatani A; Masamune A; Shimosegawa T
    Dig Dis Sci; 2018 Feb; 63(2):345-355. PubMed ID: 29282639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glutathione peroxidases as oncotargets.
    Jiao Y; Wang Y; Guo S; Wang G
    Oncotarget; 2017 Oct; 8(45):80093-80102. PubMed ID: 29108391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma.
    Lei Z; Tian D; Zhang C; Zhao S; Su M
    BMC Cancer; 2016 Jul; 16():410. PubMed ID: 27388201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selenium. Role of the essential metalloid in health.
    Kurokawa S; Berry MJ
    Met Ions Life Sci; 2013; 13():499-534. PubMed ID: 24470102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from Barrett's esophagus: results from biomarkers and genetic variants.
    Takata Y; Kristal AR; Santella RM; King IB; Duggan DJ; Lampe JW; Rayman MP; Blount PL; Reid BJ; Vaughan TL; Peters U
    PLoS One; 2012; 7(6):e38612. PubMed ID: 22715394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic variation in GPX1 is associated with GPX1 activity in a comprehensive analysis of genetic variations in selenoenzyme genes and their activity and oxidative stress in humans.
    Takata Y; King IB; Lampe JW; Burk RF; Hill KE; Santella RM; Kristal AR; Duggan DJ; Vaughan TL; Peters U
    J Nutr; 2012 Mar; 142(3):419-26. PubMed ID: 22259188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment for Barrett's oesophagus.
    Rees JR; Lao-Sirieix P; Wong A; Fitzgerald RC
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD004060. PubMed ID: 20091557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.